North Andover, MA, United States of America

Rajesh Shukla

This inventor holds 1 USPTO granted patent. Top assignee: Immunomolecular Therapeutics, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajesh Shukla. Retrieved from https://idiyas.com/inventor/rajesh-shukla-tpvwajlc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Rajesh Shukla

Introduction

Rajesh Shukla is a notable inventor based in North Andover, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. His work has led to advancements that benefit both the scientific community and patients alike.

Latest Patents

Rajesh Shukla holds a patent for "Methods for producing D-α-methyldopa." This invention provides methods for synthesizing D-α-methyldopa and L-α-methyldopa, which are crucial in the treatment of hypertension. His innovative approach in this area showcases his expertise and dedication to improving medical therapies.

Career Highlights

Rajesh is currently employed at Immunomolecular Therapeutics, Inc., where he continues to work on groundbreaking research. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

One of his notable coworkers is Xing Fu, with whom he collaborates on various projects. Their combined expertise fosters a productive environment that encourages the development of new therapeutic methods.

Conclusion

Rajesh Shukla's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…